CYSTADENOCARCINOMA OVARY

CYSTADENOCARCINOMA OVARY was reported 6 times

These drug classes are most commonly taken by patients reporting CYSTADENOCARCINOMA OVARY:

# Drug Count
0 Anti-IgE [EPC] 1
1 CD20-directed Cytolytic Antibody [EPC] 1
2 Corticosteroid [EPC] 1
3 Factor Xa Inhibitor [EPC] 1
4 Interleukin-17A Antagonist [EPC] 1
5 Progestin [EPC] 1
6 Progestin-containing Intrauterine System [EPC] 1